Top 3 Picks
2026 Outlook
Sector trends through 2026 center on expanded telehealth integration, Medicare Advantage penetration, and regulatory tailwinds for home care, supporting mid-single-digit revenue growth for scaled operators. Smaller players with scores above 59, including EUDA and ATPC, may capture niche share as digital and wellness services accelerate adoption.
Complete Rankings
| Rank | Stock | Score | Price | Market Cap |
|---|---|---|---|---|
|
1
|
P3 Health Partners Inc. Common Stock
|
62.7 | $9.35 | $29M |
|
2
|
EUDA Health Holdings Limited Ordinary Shares
|
59.8 | $13.49 | $74M |
|
3
|
Agape ATP Corporation Common Stock
|
59.5 | $2.39 | $61M |
|
4
|
The Pennant Group, Inc. Common Stock
|
58.0 | $38.00 | $878M |
|
5
|
US Physical Therapy Inc
|
57.1 | $79.35 | $1.3B |
|
6
|
Privia Health Group, Inc. Common Stock
|
56.9 | $20.66 | $3.1B |
|
7
|
DocGo Inc. Common Stock
|
55.5 | $0.40 | $128M |
|
8
|
InnovAge Holding Corp. Common Stock
|
55.5 | $10.75 | $704M |
|
9
|
Talkspace, Inc. Warrant
|
55.4 | $0.00 | -- |
|
10
|
VSee Health, Inc. Common Stock
|
54.6 | $0.05 | $10M |
|
11
|
P3 Health Partners Inc. Warrant
|
52.3 | $0.01 | -- |
|
12
|
Talkspace, Inc. Common Stock
|
50.9 | $5.25 | $452M |
|
13
|
Omada Health, Inc. Common Stock
|
50.1 | $22.77 | $1.3B |
|
14
|
EUDA Health Holdings Limited Warrant
|
49.3 | $0.03 | -- |
|
15
|
VSee Health, Inc. Warrant
|
46.9 | $0.02 | -- |
In-Depth Analysis: Top Health Services Stocks
PIII
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
P3 Health Partners Inc. matters in the Health Services sector as a physician-led population health management company that aggregates community providers into coordinated care networks, addressing integrated delivery for patients with complex conditions.
P3 Health Partners reports weak profitability with a -6.6% profit margin and -192.6% ROE, indicating severe financial strain and operational losses despite 8.6% revenue growth.
Investors should consider PIII in 2026 for its 8.6% revenue expansion in the expanding population health management market and Tradestie Score of 62.7/100 signaling moderate upside potential. The company's network aggregation model could drive scale efficiencies and margin recovery as coordinated care demand rises. Positive sector tailwinds in value-based care may support stock appreciation if operational fixes materialize.
EUDA
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security …
EUDA Health Holdings Limited delivers non-invasive healthcare and holistic wellness products across Southeast Asia and China, with property management services generating the bulk of revenue in the Health Services sector.
EUDA posts a -40.7% profit margin, reflecting persistent losses, while recording 78.9% revenue growth that signals rapid top-line expansion. Its Tradestie Score of 59.8/100 indicates moderate overall financial positioning amid ongoing margin pressure.
EUDA's 78.9% revenue growth positions it to capture share in high-growth Asian wellness markets by 2026 as scale improves operating leverage. Conversion of property management cash flows into higher-margin holistic services could narrow the -40.7% margin and lift returns. At a Tradestie Score of 59.8/100, incremental execution gains offer a clear path to re-rating for investors focused on 2026 recovery.
ATPC
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness …
Agape ATP Corporation supplies health and wellness supplements targeting cell metabolism and detoxification within the Health Services sector, addressing demand for advisory services amid broader preventive care trends.
Profit margin of -86.3% and ROE of -5.5% reflect deep operating losses, while -93.4% revenue growth signals acute contraction in product sales and advisory volumes that undermine financial stability.
ATPC's Tradestie Score of 59.5/100 positions it for potential rebound if 2026 sector expansion in wellness products offsets prior declines through renewed supplement demand. Recovery in revenue could improve margins from current -86.3% levels, attracting investors seeking high-risk exposure to health services turnaround. Niche focus on detoxification solutions may align with sustained consumer spending if operational execution stabilizes.
PNTG
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, …
Pennant Group Inc. matters in the Health Services sector as a multi-state operator delivering home health, hospice, and senior living services to the expanding U.S. senior population.
With a 2.9% profit margin and 10.4% ROE, Pennant shows moderate returns on equity despite thin margins, supported by 35.8% revenue growth that signals scaling operations.
Investors should consider PNTG in 2026 due to its 35.8% revenue growth outpacing sector averages and exposure to senior care demand, which could lift the current 2.9% margin toward higher ROE levels. The 41.6 P/E reflects growth priced in, yet positions the stock for multiple expansion if profitability improves from 10.4% ROE. Tradestie Score of 58.0 indicates room for upside as execution continues.
USPH
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating …
US Physical Therapy Inc operates outpatient clinics delivering pre- and post-operative care for orthopedic disorders, sports injuries, and neurological conditions, filling a core niche in the Health Services sector amid rising demand for rehabilitation services. Its 8.5% revenue growth reflects expanding clinic utilization in this specialized outpatient segment.
USPH reports a 4.0% profit margin and 6.5% ROE, indicating subdued returns on equity and thin earnings conversion despite revenue expansion. The P/E of 462.6 reflects stretched valuation relative to current earnings, pointing to limited financial flexibility.
USPH's 8.5% revenue growth and 57.1/100 Tradestie Score provide a foundation for 2026 gains as Health Services demand rises for orthopedic and sports rehabilitation. Clinic network scaling could improve the 4.0% margin and lift ROE above 6.5% through volume gains. The moderate score suggests operational headroom that supports multiple expansion if utilization trends hold.
PRVA
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Privia Health Group Inc. matters in the Health Services sector as a technology-driven physician-enablement company partnering with medical groups, health plans, and health systems to optimize practices and deliver high-value care across in-person and virtual settings.
Privia reports low profitability with a 1.2% profit margin and 4.3% ROE despite 21.4% revenue growth, reflecting ongoing investments in scaling its platform amid a high P/E ratio of 94.0.
Investors should consider PRVA in 2026 for its 21.4% revenue growth trajectory in the expanding value-based care market, which positions the company to leverage physician networks and improve margins from the current 1.2% level as operational scale increases. The Tradestie Score of 56.9/100 indicates room for multiple expansion if execution on virtual care models accelerates earnings beyond the existing 4.3% ROE.
DCGO
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes …
DocGo Inc. matters in the Health Services sector as a provider of last-mile mobile health services, virtual care management, and ambulance solutions via its care delivery platform, filling integration gaps across three segments including Mobile Health Services and Transportation.
DocGo reports a -65.3% profit margin and -107.8% ROE, reflecting severe unprofitability and capital destruction, while -8.7% revenue growth signals ongoing contraction and weak financial health.
Investors may consider DCGO in 2026 as mobile health demand expands in underserved markets, potentially lifting revenue if the company stabilizes its three segments. The 55.5/100 Tradestie Score indicates baseline operational viability that could improve with scale efficiencies. A shift to positive revenue growth from virtual care management would support margin recovery and ROE normalization.
INNV
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of …
InnovAge Holding Corp operates a capitated care platform serving high-cost dual-eligible seniors, directly targeting U.S. healthcare cost and quality challenges in the Health Services sector through all-inclusive participant models.
Profit margin of -1.2% and ROE of -5.9% reflect current unprofitability and negative returns on equity, while 15.5% revenue growth signals operational expansion despite thin margins.
Revenue growth of 15.5% positions INNV for scale in the expanding senior care market by 2026 as capitated models gain adoption. Margin improvement from the current -1.2% level could drive ROE above -5.9% with volume gains. The 55.5/100 Tradestie Score indicates room for valuation upside as profitability stabilizes.
TALKW
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of …
Talkspace matters in the Health Services sector as a digital platform delivering licensed therapist, psychologist, and psychiatrist access to health plans, enterprises, and individual subscribers for mental health conditions.
Limited financial data and a Tradestie Score of 55.4/100 indicate moderate financial health with constrained profitability metrics amid platform scaling.
TALKW warrants offer leveraged exposure to Talkspace's growth as enterprise and health plan adoption expands virtual behavioral health services. Rising mental health demand supports subscriber increases through 2026, potentially driving revenue and warrant value appreciation. The 55.4/100 score leaves room for upside if operational efficiencies improve profitability.
VSEE
VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted …
VSee Health Inc. delivers a HIPAA-compliant telehealth platform with secure text-video collaboration, customizable virtual waiting rooms, and workflow-integrated clinics, addressing rising demand for scalable digital care in the Health Services sector.
VSEE reports a -92.4% profit margin and -945.7% ROE alongside -4.9% revenue contraction, reflecting acute unprofitability and strained financial health in its current operations.
VSEE's proprietary platform offers workflow customization that could capture share in expanding telehealth demand by 2026; its 54.6/100 Tradestie Score indicates baseline market viability with upside if revenue stabilizes; sector-wide digital health adoption may support valuation recovery despite near-term metrics.
Methodology
Stocks are ranked using the Tradestie Score, a proprietary 0-100 rating that combines fundamental quality (profitability, balance sheet strength), growth metrics (revenue and earnings growth), valuation (P/E, PEG ratio), and momentum factors. Scores are updated daily based on the latest market data. Learn more about our methodology.